866084-31-3,MFCD28978558
Catalog No.:AA00GU42

866084-31-3 | tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
1 week  
$54.00   $38.00
- +
250mg
97%
1 week  
$102.00   $72.00
- +
1g
97%
1 week  
$218.00   $153.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GU42
Chemical Name:
tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
CAS Number:
866084-31-3
Molecular Formula:
C32H43N7O4
Molecular Weight:
589.7283
MDL Number:
MFCD28978558
SMILES:
CCCOC(=C)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCN(CC1)C(=O)OC(C)(C)C
Properties

Downstream Synthesis Route
tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  107-36-8   
PD0332991isethionate 

[1]Patent:WO2005/5426,2005,A1.Locationinpatent:Page/Pagecolumn25;26

[2]Patent:US2005/222163,2005,A1.Locationinpatent:Page/Pagecolumn28

[3]Patent:WO2008/32157,2008,A2.Locationinpatent:Page/Pagecolumn28

[1]CurrentPatentAssignee:PFIZERINC-WO2014/128588,2014,A1

[2]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2016/30439,2016,A1

[3]CurrentPatentAssignee:TETRANOVBIOPHARM-CN104447739,2016,B

[4]CurrentPatentAssignee:NANJINGNMGADDS-CN105541832,2016,A

[5]CurrentPatentAssignee:HEFEIYUANZHIPHARMACEUTICALRD-CN106220627,2016,A

[6]CurrentPatentAssignee:KINGLAWRENCE;CIPLALTD-WO2018/73574,2018,A1

[7]CurrentPatentAssignee:CHONGQINGSANSHENG-CN109336886,2019,A

[8]Su,Shang;Yang,Zimo;Gao,Hongying;Yang,Haiyan;Zhu,Songbiao;An,Zixuan;Wang,Juanjuan;Li,Qing;Chandarlapaty,Sarat;Deng,Haiteng;Wu,Wei;Rao,Yu[JournalofMedicinalChemistry,2019,vol.62,#16,p.7575-7582]

[9]CurrentPatentAssignee:JIANGXIGUOYAOPHARMACEUTICAL-CN112552297,2021,A

tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  571190-30-2 

[1]Patent:WO2014/128588,2014,A1.Locationinpatent:Page/Pagecolumn39;40;41

[2]Patent:CN109336886,2019,A.Locationinpatent:Paragraph0039;0042;0043;0047

[3]Patent:CN105541832,2016,A.Locationinpatent:Paragraph0047;0048;0049;0066;0067;0068

[4]Patent:WO2016/30439,2016,A1.Locationinpatent:Page/Pagecolumn36

[5]ChemicalPapers,2019,vol.73,p.3043-3051

[6]Patent:CN104447739,2016,B

[7]Patent:CN106220627,2016,A

[8]Patent:CN106220627,2016,A

[9]Patent:CN106397431,2017,A

[10]Patent:WO2018/73574,2018,A1

[11]Patent:US2018/319790,2018,A1

[12]Patent:WO2018/7927,2018,A1

[13]Patent:WO2018/7927,2018,A1

[14]Patent:WO2018/7927,2018,A1

[15]JournalofMedicinalChemistry,2019,vol.62,p.7575-7582

[16]Patent:WO2019/224194,2019,A1.Locationinpatent:Page/Pagecolumn13

tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  827022-32-2 

[1]Patent:CN105924439,2016,A.Locationinpatent:Paragraph0042

[2]Patent:CN106397431,2017,A.Locationinpatent:Paragraph0089;0090;0091;0092

[1]CurrentPatentAssignee:SUZHOUGUOKUANGPHARMACEUTICALTECH-CN106397431,2017,ALocationinpatent:Paragraph0097;0098;0099;0100

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 866084-31-3
Tags:866084-31-3 Molecular Formula|866084-31-3 MDL|866084-31-3 SMILES|866084-31-3 tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Catalog No.: AA00GU42
866084-31-3,MFCD28978558
866084-31-3 | tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pack Size: 100mg
Purity: 97%
1 week
$54.00 $38.00
Pack Size: 250mg
Purity: 97%
1 week
$102.00 $72.00
Pack Size: 1g
Purity: 97%
1 week
$218.00 $153.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GU42
Chemical Name: tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
CAS Number: 866084-31-3
Molecular Formula: C32H43N7O4
Molecular Weight: 589.7283
MDL Number: MFCD28978558
SMILES: CCCOC(=C)c1c(C)c2cnc(nc2n(c1=O)C1CCCC1)Nc1ccc(cn1)N1CCN(CC1)C(=O)OC(C)(C)C
Properties
Downstream Synthesis Route
tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  107-36-8   
PD0332991isethionate 

[1]Patent:WO2005/5426,2005,A1.Locationinpatent:Page/Pagecolumn25;26

[2]Patent:US2005/222163,2005,A1.Locationinpatent:Page/Pagecolumn28

[3]Patent:WO2008/32157,2008,A2.Locationinpatent:Page/Pagecolumn28

1016636-76-2    866084-31-3 

[1]CurrentPatentAssignee:PFIZERINC-WO2014/128588,2014,A1

[2]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2016/30439,2016,A1

[3]CurrentPatentAssignee:TETRANOVBIOPHARM-CN104447739,2016,B

[4]CurrentPatentAssignee:NANJINGNMGADDS-CN105541832,2016,A

[5]CurrentPatentAssignee:HEFEIYUANZHIPHARMACEUTICALRD-CN106220627,2016,A

[6]CurrentPatentAssignee:KINGLAWRENCE;CIPLALTD-WO2018/73574,2018,A1

[7]CurrentPatentAssignee:CHONGQINGSANSHENG-CN109336886,2019,A

[8]Su,Shang;Yang,Zimo;Gao,Hongying;Yang,Haiyan;Zhu,Songbiao;An,Zixuan;Wang,Juanjuan;Li,Qing;Chandarlapaty,Sarat;Deng,Haiteng;Wu,Wei;Rao,Yu[JournalofMedicinalChemistry,2019,vol.62,#16,p.7575-7582]

[9]CurrentPatentAssignee:JIANGXIGUOYAOPHARMACEUTICAL-CN112552297,2021,A

tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  571190-30-2 

[1]Patent:WO2014/128588,2014,A1.Locationinpatent:Page/Pagecolumn39;40;41

[2]Patent:CN109336886,2019,A.Locationinpatent:Paragraph0039;0042;0043;0047

[3]Patent:CN105541832,2016,A.Locationinpatent:Paragraph0047;0048;0049;0066;0067;0068

[4]Patent:WO2016/30439,2016,A1.Locationinpatent:Page/Pagecolumn36

[5]ChemicalPapers,2019,vol.73,p.3043-3051

[6]Patent:CN104447739,2016,B

[7]Patent:CN106220627,2016,A

[8]Patent:CN106220627,2016,A

[9]Patent:CN106397431,2017,A

[10]Patent:WO2018/73574,2018,A1

[11]Patent:US2018/319790,2018,A1

[12]Patent:WO2018/7927,2018,A1

[13]Patent:WO2018/7927,2018,A1

[14]Patent:WO2018/7927,2018,A1

[15]JournalofMedicinalChemistry,2019,vol.62,p.7575-7582

[16]Patent:WO2019/224194,2019,A1.Locationinpatent:Page/Pagecolumn13

tert‑butyl4‑(6‑((6‑(1‑butoxyvinyl)‑8‑cyclopentyl‑5‑methyl‑7‑oxo‑7,8‑dihydropyrido2,3‑dpyrimidin‑2‑yl)amino)pyridin‑3‑yl)piperazine‑1‑carboxylate 
  827022-32-2 

[1]Patent:CN105924439,2016,A.Locationinpatent:Paragraph0042

[2]Patent:CN106397431,2017,A.Locationinpatent:Paragraph0089;0090;0091;0092

866084-31-3    827022-33-3 

[1]CurrentPatentAssignee:SUZHOUGUOKUANGPHARMACEUTICALTECH-CN106397431,2017,ALocationinpatent:Paragraph0097;0098;0099;0100

Building Blocks More >
871726-72-6
871726-72-6
1-Boc-4-[(dimethylamino)methylene]-3-oxopiperidine
AA00H3OW | MFCD22565632
1390656-66-2
1390656-66-2
5,7-Dichloropyrido[3,4-d]pyridazin-4(3h)-one
AA00HVA7 | MFCD23163509
1820618-21-0
1820618-21-0
2-Chloro-4,5,6,7-tetrahydro-benzothiazole-6-carboxylic acid ethyl ester
AA00I0H4 | MFCD27918618
1956319-58-6
1956319-58-6
Ethyl 2-amino-2-(3-chloropyridin-4-yl)acetate hydrochloride
AA00I3C4 | MFCD30186146
866933-34-8
866933-34-8
(S)-Benzyl 1-(methylamino)propan-2-ylcarbamate
AA00IE3U | MFCD18642565
957035-19-7
957035-19-7
6-Bromoimidazo[1,2-a]pyridine, HCl
AA00IJAI | MFCD09475874
1609396-63-5
1609396-63-5
5-(1H-imidazol-2-yl)-2-thiophenecarboxylic acid hydrate
AA00J0V2 | MFCD13193802
139-40-2
139-40-2
6-Chloro-N2,N4-diisopropyl-1,3,5-triazine-2,4-diamine
AA019CEM | MFCD00047341
22236-06-2
22236-06-2
2-(Difluoromethoxy)-4-nitroaniline
AA019U4W | MFCD00270186
926206-96-4
926206-96-4
3-phenyl-1-(piperazin-1-yl)butan-1-one
AA019WJA | MFCD08443255
Submit
© 2017 AA BLOCKS, INC. All rights reserved.